probenecid has been researched along with ethidium in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhaskaracharya, A; Dao-Ung, P; Fuller, SJ; Jalilian, I; Skarratt, KK; Sluyter, R; Spildrejorde, M; Stokes, L | 1 |
| Chen, G; Li, HY; Ling, ZM; Wang, Q; Wei, ZY | 1 |
2 other study(ies) available for probenecid and ethidium
| Article | Year |
|---|---|
Probenecid blocks human P2X7 receptor-induced dye uptake via a pannexin-1 independent mechanism.
Topics: Adenosine Triphosphate; Biological Transport, Active; Calcium Signaling; Connexins; Ethidium; Fluorescent Dyes; HEK293 Cells; Humans; Inhibitory Concentration 50; Interleukin-1beta; Isoquinolines; Lipopolysaccharides; Monocytes; Nerve Tissue Proteins; Probenecid; Purinergic P2X Receptor Antagonists; Receptors, Purinergic P2X7 | 2014 |
Inhibition of Schwann cell pannexin 1 attenuates neuropathic pain through the suppression of inflammatory responses.
Topics: Adenosine Triphosphate; Animals; Carbenoxolone; Connexins; Cytokines; Ethidium; Hyperalgesia; Lipopolysaccharides; Mice; Nerve Tissue Proteins; Neuralgia; Probenecid; RNA, Small Interfering; Schwann Cells | 2022 |